| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$730,000 | |
| 2026 | APOTEX CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$730,000 | |
| 2025 | APOTEX CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$260,000 | |
| 2025 | APOTEX CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$310,000 | |
| 2025 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$300,000 | |
| 2025 | APOTEX CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$810,000 | |
| 2024 | APOTEX CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$220,000 | |
| 2024 | APOTEX CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$160,000 | |
| 2024 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$160,000 | |
| 2024 | APOTEX CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$140,000 |
| Firm | Filings | Expenses |
|---|---|---|
| APOTEX CORP. | 83 | $16,958,300 |
| Issue | Activities |
|---|---|
| Pharmacy | 61 |
| Copyright/Patent/Trademark | 21 |
| Manufacturing | 19 |
| Health Issues | 19 |
| Medicare/Medicaid | 17 |
| Trade (domestic/foreign) | 13 |
| Budget/Appropriations | 7 |
| Tariff (miscellaneous tariff bills) | 4 |